Annual CFF
$122.75 M
+$75.97 M+162.42%
December 31, 2023
Summary
- As of February 8, 2025, FGEN annual cash flow from financing activities is $122.75 million, with the most recent change of +$75.97 million (+162.42%) on December 31, 2023.
- During the last 3 years, FGEN annual CFF has risen by +$109.41 million (+819.95%).
- FGEN annual CFF is now -75.28% below its all-time high of $496.47 million, reached on December 31, 2017.
Performance
FGEN Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFF
-$127.00 K
-$159.00 K-496.88%
September 30, 2024
Summary
- As of February 8, 2025, FGEN quarterly cash flow from financing activities is -$127.00 thousand, with the most recent change of -$159.00 thousand (-496.88%) on September 30, 2024.
- Over the past year, FGEN quarterly CFF has stayed the same.
- FGEN quarterly CFF is now -100.03% below its all-time high of $370.02 million, reached on September 30, 2017.
Performance
FGEN Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFF
-$506.00 K
-$105.00 K-26.18%
September 30, 2024
Summary
- As of February 8, 2025, FGEN TTM cash flow from financing activities is -$506.00 thousand, with the most recent change of -$105.00 thousand (-26.18%) on September 30, 2024.
- Over the past year, FGEN TTM CFF has stayed the same.
- FGEN TTM CFF is now -100.10% below its all-time high of $497.94 million, reached on March 31, 2018.
Performance
FGEN TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Financing Formula
CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities
FGEN Cash From Financing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +162.4% | 0.0% | 0.0% |
| 3 y3 years | +820.0% | 0.0% | 0.0% |
| 5 y5 years | +784.7% | 0.0% | 0.0% |
FGEN Cash From Financing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | >+9999.0% | -100.1% | +95.6% | -100.3% | +73.8% |
| 5 y | 5-year | at high | +2954.6% | -100.1% | +95.6% | -100.3% | +88.2% |
| alltime | all time | -75.3% | +2954.6% | -100.0% | +96.4% | -100.1% | +88.2% |
FibroGen Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$127.00 K(-496.9%) | -$506.00 K(+26.2%) |
| Jun 2024 | - | $32.00 K(-119.4%) | -$401.00 K(-100.4%) |
| Mar 2024 | - | -$165.00 K(-32.9%) | $91.10 M(-25.8%) |
| Dec 2023 | $122.75 M(+162.4%) | -$246.00 K(+1018.2%) | $122.75 M(-28.5%) |
| Sep 2023 | - | -$22.00 K(-100.0%) | $171.67 M(+0.6%) |
| Jun 2023 | - | $91.53 M(+190.7%) | $170.60 M(+110.2%) |
| Mar 2023 | - | $31.48 M(-35.3%) | $81.15 M(+73.5%) |
| Dec 2022 | $46.78 M(-8408.3%) | $48.67 M(-4557.3%) | $46.78 M(-2524.9%) |
| Sep 2022 | - | -$1.09 M(-152.3%) | -$1.93 M(+15.5%) |
| Jun 2022 | - | $2.09 M(-172.1%) | -$1.67 M(+21.4%) |
| Mar 2022 | - | -$2.89 M(+9232.3%) | -$1.38 M(+144.4%) |
| Dec 2021 | -$563.00 K(-104.2%) | -$31.00 K(-96.3%) | -$563.00 K(-111.0%) |
| Sep 2021 | - | -$833.00 K(-135.0%) | $5.13 M(-49.7%) |
| Jun 2021 | - | $2.38 M(-214.5%) | $10.19 M(-18.2%) |
| Mar 2021 | - | -$2.08 M(-136.8%) | $12.45 M(-6.7%) |
| Dec 2020 | $13.34 M(-410.3%) | $5.66 M(+33.9%) | $13.34 M(+80.3%) |
| Sep 2020 | - | $4.22 M(-9.1%) | $7.40 M(<-9900.0%) |
| Jun 2020 | - | $4.65 M(-490.7%) | -$61.00 K(-96.9%) |
| Mar 2020 | - | -$1.19 M(+319.0%) | -$1.96 M(-54.5%) |
| Dec 2019 | -$4.30 M | -$284.00 K(-91.2%) | -$4.30 M(+258.9%) |
| Sep 2019 | - | -$3.24 M(-217.5%) | -$1.20 M(-120.1%) |
| Jun 2019 | - | $2.75 M(-177.9%) | $5.96 M(-28.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2019 | - | -$3.53 M(-225.4%) | $8.30 M(-40.2%) |
| Dec 2018 | $13.88 M(-97.2%) | $2.82 M(-28.1%) | $13.88 M(-4.1%) |
| Sep 2018 | - | $3.92 M(-23.0%) | $14.47 M(-96.2%) |
| Jun 2018 | - | $5.09 M(+149.0%) | $380.57 M(-23.6%) |
| Mar 2018 | - | $2.04 M(-40.1%) | $497.94 M(+0.3%) |
| Dec 2017 | $496.47 M(+7268.2%) | $3.41 M(-99.1%) | $496.47 M(+0.1%) |
| Sep 2017 | - | $370.02 M(+202.2%) | $496.20 M(+289.9%) |
| Jun 2017 | - | $122.46 M(>+9900.0%) | $127.27 M(+1605.8%) |
| Mar 2017 | - | $574.00 K(-81.7%) | $7.46 M(+10.7%) |
| Dec 2016 | $6.74 M(-45.4%) | $3.15 M(+188.8%) | $6.74 M(-12.7%) |
| Sep 2016 | - | $1.09 M(-59.0%) | $7.72 M(-18.3%) |
| Jun 2016 | - | $2.65 M(-1880.5%) | $9.44 M(-18.4%) |
| Mar 2016 | - | -$149.00 K(-103.6%) | $11.58 M(-6.2%) |
| Dec 2015 | $12.35 M(-92.9%) | $4.13 M(+46.6%) | $12.35 M(-93.3%) |
| Sep 2015 | - | $2.81 M(-41.2%) | $183.88 M(+2.1%) |
| Jun 2015 | - | $4.79 M(+672.1%) | $180.04 M(+3.0%) |
| Mar 2015 | - | $620.00 K(-99.6%) | $174.78 M(+0.4%) |
| Dec 2014 | $174.09 M(>+9900.0%) | $175.66 M(<-9900.0%) | $174.09 M(<-9900.0%) |
| Sep 2014 | - | -$1.03 M(+118.6%) | -$1.57 M(+192.6%) |
| Jun 2014 | - | -$473.00 K(+639.1%) | -$537.00 K(+739.1%) |
| Mar 2014 | - | -$64.00 K | -$64.00 K |
| Dec 2013 | $680.00 K(-90.0%) | - | - |
| Dec 2012 | $6.81 M | - | - |
FAQ
- What is FibroGen annual cash flow from financing activities?
- What is the all time high annual CFF for FibroGen?
- What is FibroGen annual CFF year-on-year change?
- What is FibroGen quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for FibroGen?
- What is FibroGen quarterly CFF year-on-year change?
- What is FibroGen TTM cash flow from financing activities?
- What is the all time high TTM CFF for FibroGen?
- What is FibroGen TTM CFF year-on-year change?
What is FibroGen annual cash flow from financing activities?
The current annual CFF of FGEN is $122.75 M
What is the all time high annual CFF for FibroGen?
FibroGen all-time high annual cash flow from financing activities is $496.47 M
What is FibroGen annual CFF year-on-year change?
Over the past year, FGEN annual cash flow from financing activities has changed by +$75.97 M (+162.42%)
What is FibroGen quarterly cash flow from financing activities?
The current quarterly CFF of FGEN is -$127.00 K
What is the all time high quarterly CFF for FibroGen?
FibroGen all-time high quarterly cash flow from financing activities is $370.02 M
What is FibroGen quarterly CFF year-on-year change?
Over the past year, FGEN quarterly cash flow from financing activities has changed by $0.00 (0.00%)
What is FibroGen TTM cash flow from financing activities?
The current TTM CFF of FGEN is -$506.00 K
What is the all time high TTM CFF for FibroGen?
FibroGen all-time high TTM cash flow from financing activities is $497.94 M
What is FibroGen TTM CFF year-on-year change?
Over the past year, FGEN TTM cash flow from financing activities has changed by $0.00 (0.00%)